NASDAQ: AVDL
Avadel Pharmaceuticals PLC Stock Ownership - Who owns Avadel Pharmaceuticals?

Insider buying vs selling

Have Avadel Pharmaceuticals PLC insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when AVDL insiders and whales buy or sell their stock.

AVDL Shareholders

What type of owners hold Avadel Pharmaceuticals PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Janus Henderson Group PLC7.61%7,429,718$161.15MInstitution
Blackrock Inc7.14%6,973,658$151.26MInstitution
Vanguard Group Inc5.74%5,606,282$121.60MInstitution
Brandes Investment Partners LP5.58%5,444,803$118.10MInstitution
Two Seas Capital LP5.50%5,369,082$116.46MInstitution
Gendell Jeffrey L5.44%5,314,810$115.28MInstitution
Broadfin Healthcare Master Fund Ltd4.23%4,133,464$89.65MInsider
Polar Capital Holdings PLC4.10%3,999,338$86.75MInstitution
James E. Flynn3.76%3,674,506$79.70MInsider
Kevin Kotler3.21%3,130,573$67.90MInsider

1 of 3

AVDL vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVDL81.67%13.55%
PAHC43.59%56.41%Net SellingNet Selling
BHC50.60%49.40%Net BuyingNet Buying
PRGO64.25%35.75%Net BuyingNet Buying
ANIP29.82%70.18%Net SellingNet Selling

Avadel Pharmaceuticals Stock Ownership FAQ

Who owns Avadel Pharmaceuticals?

Avadel Pharmaceuticals (NASDAQ: AVDL) is owned by 81.67% institutional shareholders, 13.55% Avadel Pharmaceuticals insiders, and 4.78% retail investors. Broadfin Healthcare Master Fund Ltd is the largest individual Avadel Pharmaceuticals shareholder, owning 4.13M shares representing 4.23% of the company. Broadfin Healthcare Master Fund Ltd's Avadel Pharmaceuticals shares are currently valued at $89.65M.

If you're new to stock investing, here's how to buy Avadel Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.